A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/21 (2006.01) A61K 38/17 (2006.01) A61K 38/19 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2471586
The invention relates to the use of an agent having, stimulating or maintaining tumor necrosis factor (TNF) activity, together with an interferon (IFN) for treating and/or preventing demyelinating diseases, in particular multiple sclerosis (MS). The use of a combination of a TNF or a tumor necrosis factor binding protein in combination with an interferon for treating and/or preventing demyelinating diseases is preferred.
L'invention concerne l'utilisation d'un agent possédant, stimulant ou maintenant une activité de facteur de nécrose de tumeurs (TNF), conjointement avec un interféron (IFN) pour traiter et/ou prévenir des maladies démyélinisantes, en particulier la sclérose en plaques. Elle concerne de préférence l'utilisation combinée d'un TNF ou d'une protéine se liant à un facteur de nécrose de tumeurs, et d'un interféron pour traiter et/ou prévenir des maladies démyélinisantes.
Ares Trading S.a.
Kirby Eades Gale Baker
LandOfFree
Tumor necrosis factor combined with interferon in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor necrosis factor combined with interferon in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor necrosis factor combined with interferon in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1612498